Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aducanumab and Its Effects on Tau Pathology: Is This the Turning Point of Amyloid Hypothesis?
Serena Silvestro, Andrea Valeri, Emanuela Mazzon
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2011-2011
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Role of Aducanumab in the Treatment of Alzheimer’s Disease: Challenges and Opportunities
Miguel Vaz, Vítor Silva, Cristina Monteiro, et al.
Clinical Interventions in Aging (2022) Vol. Volume 17, pp. 797-810
Open Access | Times Cited: 117
Pharmacotherapy Evolution in Alzheimer’s Disease: Current Framework and Relevant Directions
Denisa Claudia Miculas, Paul Andrei Negru, Simona Bungău, et al.
Cells (2022) Vol. 12, Iss. 1, pp. 131-131
Open Access | Times Cited: 45
Photobiomodulation in Alzheimer’s Disease—A Complementary Method to State-of-the-Art Pharmaceutical Formulations and Nanomedicine?
Laura Marinela Ailioaie, Constantin Ailioaie, Gerhard Litscher
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 916-916
Open Access | Times Cited: 22
Molecular mechanisms in Alzheimer's disease and related potential treatments such as structural target convergence of antibodies and simple organic molecules
Nassima Oumata, Kui Lu, Yuou Teng, et al.
European Journal of Medicinal Chemistry (2022) Vol. 240, pp. 114578-114578
Closed Access | Times Cited: 29
Mesenchymal Stem Cell-Derived Extracellular Vesicles: An Emerging Diagnostic and Therapeutic Biomolecules for Neurodegenerative Disabilities
Mahmoud Kandeel, Mohamed A. Morsy, Khalid M. Alkhodair, et al.
Biomolecules (2023) Vol. 13, Iss. 8, pp. 1250-1250
Open Access | Times Cited: 16
A systematic review and meta-analysis of tau phosphorylation in mouse models of familial Alzheimer's disease
Malamati Kourti, Athanasios Metaxas
Neurobiology of Disease (2024) Vol. 192, pp. 106427-106427
Open Access | Times Cited: 6
Research progress in traditional Chinese medicine in the treatment of Alzheimer’s disease and related dementias
Wanying Tan, Lingjun Qi, Xiaoyu Hu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 26
Therapeutics of Alzheimer’s Disease: Recent Developments
Scott Burns, Ashley Selman, Ujala Sehar, et al.
Antioxidants (2022) Vol. 11, Iss. 12, pp. 2402-2402
Open Access | Times Cited: 25
Tau- and α-synuclein-targeted gold nanoparticles: applications, opportunities, and future outlooks in the diagnosis and therapy of neurodegenerative diseases
Andreas Tapia-Arellano, Pablo Cabrera, Elizabeth Cortés-Adasme, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Evolution of Alzheimer’s Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy
Emma Ortiz, Pedro Montes, Citlali Ekaterina Rodríguez-Pérez, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 128-128
Open Access
Perivascular brain clearance as a therapeutic target in cerebral amyloid angiopathy and Alzheimer's disease
Orla Bonnar, Beth Eyre, Susanne J. van Veluw
Neurotherapeutics (2025), pp. e00535-e00535
Open Access
The abnormal accumulation of pathological proteins and compensatory functional connectivity enhancement of insula subdivisions in mild cognitive impairment
Darui Zheng, Chen Xue, Yunlu Feng, et al.
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access
Targeting the Brain with Single-Domain Antibodies: Greater Potential Than Stated So Far?
Mireille Elodie Tsitokana, Pierre‐André Lafon, Laurent Prézeau, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2632-2632
Open Access | Times Cited: 11
The relationship between protein modified folding molecular network and Alzheimer’s disease pathogenesis based on BAG2-HSC70-STUB1-MAPT expression patterns analysis
Xiaolong Yang, Wenbo Guo, Lin Yang, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 11
A Narrative Review of the Effects of Citrus Peels and Extracts on Human Brain Health and Metabolism
Kentaro Matsuzaki, Akira Nakajima, Yuanqiang Guo, et al.
Nutrients (2022) Vol. 14, Iss. 9, pp. 1847-1847
Open Access | Times Cited: 16
Human cystatin C induces the disaggregation process of selected amyloid beta peptides: a structural and kinetic view
Adriana Żyła, Anne Martel, Przemysław Jurczak, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
The interplay of epilepsy with impaired mitophagy and autophagy linked dementia (MAD): A review of therapeutic approaches
Siva Prasad Panda, Yogita Dhurandhar, Mehak Agrawal
Mitochondrion (2022) Vol. 66, pp. 27-37
Closed Access | Times Cited: 10
Regional AT-8 reactive tau species correlate with intracellular Aβ levels in cases of low AD neuropathologic change
Nauman Malik, Mohi-Uddin Miah, Alessandro Galgani, et al.
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Open Access | Times Cited: 1
Generating PET scan patterns in Alzheimer’s by a mathematical model
Chaeyoung Lee, Avner Friedman
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0299637-e0299637
Open Access | Times Cited: 1
ACSL3 is a promising therapeutic target for alleviating anxiety and depression in Alzheimer’s disease
Celeste Yin‐Chieh Wu, Yulan Zhang, Peyton Grace Howard, et al.
GeroScience (2024)
Open Access | Times Cited: 1
Amylin and Secretases in the Pathology and Treatment of Alzheimer’s Disease
Som Singh, Felix Yang, Andy Sivils, et al.
Biomolecules (2022) Vol. 12, Iss. 7, pp. 996-996
Open Access | Times Cited: 7
Nanoporous Membranes for the Filtration of Proteins from Biological Fluids: Biocompatibility Tests on Cell Cultures and Suggested Applications for the Treatment of Alzheimer’s Disease
Thomas Gabriel Schreiner, Bogdan Ionel Tamba, Cosmin Mihai, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 19, pp. 5846-5846
Open Access | Times Cited: 6
Dual Role of Inositol-requiring Enzyme 1α–X-box Binding protein 1 Signaling in Neurodegenerative Diseases
Cailin Wang, Yanmin Chang, Jiahui Zhu, et al.
Neuroscience (2022) Vol. 505, pp. 157-170
Closed Access | Times Cited: 6
Aducanumab: an uprising hope with vague horizons
Delara Hazegh Fetratjoo, Alireza Kargar, Maryam Noroozıan
The Egyptian Journal of Neurology Psychiatry and Neurosurgery (2023) Vol. 59, Iss. 1
Open Access | Times Cited: 2
Recent Treatment Strategies in Alzheimer's Disease and Chronic Traumatic Encephalopathy
Brandon Lucke–Wold
Biomedical Research and Clinical Reviews (2022) Vol. 7, Iss. 3, pp. 01-14
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top